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1. Introduction 
It has been found recently that viral and 
eucaryotic mRNA contain different abnormal 
structures at their 5’-termini [l] . The biological 
significance of this so called cap structure is not 
clearly understood. A general feature of the 
approach made by several groups to determine the 
function of cap structure is to modify a specific 
mRNA by removing the inverted nucleoside at the 
5’-terminus. The translational efficiency of the 
modified mRNA is then compared with that of 
normal mRNA in a reconstituted system. 
Periodate oxidation and aniline treatment has 
been employed to eliminate the terminal ribose 
moietes containing free-OH groups in both 2 and 
3 positions (p elimination) [2,3]. Such chemical 
modification of mRNA is rather drastic and results 
in mRNA with abnormal termini at both ends of the 
molecule. In this paper we report a novel method 
for the removal of the blocking nucleotide m’ GDP 
from the 5’-terminus of eucaryotic mRNA. 
2. Experimental 
2.1. Preparation of mRNA 
Total RNA was extracted essentially as described 
earlier [4] from membrane-bound ribosome fractions 
of a kappa chain producing mouse plasmacytoma 
cell line, MPC- 11, grown in the presence of carrier 
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free [“‘PI Pi for 16 h. Polyadenylated RNA was 
separated by chromatography on oligo(dT)-cellulose 
columns [5] . 
2.2. Isolation of cap structures 
Capped structures were isolated from labelled 
mRNA by mild alkaline hydrolysis [6], followed by 
chromatography on a DEAE-cellulose column [7]. 
The broad radioactive peak eluted from the column 
immediately after UTP marker was freeze dried and 
dissolved in H2 0. 
2.3. Enzymatic cleavage of the cap structure 
Bacteriophage Tq-induced polynucleotide 
kinase isolated according to Panet et al. [8] was 
used to cleave the cap structure. The reaction mixture 
contained per 0.2 ml: 65 mM Tris-HCl (pH 7.8) 
15 mM mercaptoethanol, 9 mM magnesium chloride, 
30 pg mRNA or cap structures isolated from 50 pg 
mRNA, and 3 units of highly purified polynucleotide 
kinase. After 30 min at 3O”C, the reaction was 
stopped by adding EDTA [9]. 
3. Results 
Cap structure of microsomal mRNAs from 
myeloma cells contain a minimum of 27 different 
sequences of the 32 possible ones [lo] . All of them 
contain 7 methyl guanosine attached to the rest 
of the molecule through a 5’-5’ triphosphate 
linkage [lo] . The present method for the cleavage 
of m’ GDP involves the use of polynucleotide 
kinase. The enzyme normally transfers the terminal 
phosphate of a triphosphate to the free hydroxyl 
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group of the ribose moiety of a polynucleotide. 
Under suitable conditions, the enzyme can also 
catalyze the reverse reaction. Thus when 5’- 
[““PI labelled oligonucleotide is incubated with 
ADP and polynucleotide kinase, [Y-~*P] ATP is 
formed [9]. Since it seemed likely that the 
forward and the backward reactions might be 
catalysed through the formation of an intermediate 
analogous to that found in the capped mRNA, we 
studied the action of polynucleotide kinase on cap 
structures. Hence it would be expected that cap 
structure may be split between /3 and y phosphate 
groups by the enzyme, producing m7 GDP. 
Treatment of [“PI Pi-labelled cap structure with 
polynucleotide kinase produced cleavage products 
that comigrated with GDP and GMP on paper 
chromatography (fig. 1). 7-Methylguanosine 
containing compounds are alkali labile [ 111. Pro- 
longed treatment with strong alkali produces the 
open ring structure that has lost the extra positive 
charge of 7-methyl-guanine [ 1 I] . A partial conversion 
to the open ring form would be expected to occur 
during the isolation of the cap structure [6]. It is 
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Fig. 1. Paper chromatography of polynucleotide kinase treated 
cap structure. Isolation of cap structure and treatment with 
polynucleotide kinase was as described in the experimental 
section. At the end of the reaction material was analysed 
by descending paper chromatography in isobutyric acid/O.SN 
NH, OH (10:6; v/v), using GDP and GMP as optical markers. 
(A) Control, (B) polynucleotide kinase treated. 
not surprising, therefore, that the cleavage products 
produced migrated as broad peak (fig. 1). 
3.1. Cleavage of m7 GDP from Intact mRNA 
[32P] Pi-labelled mRNA treated with poly- 
nucleotide kinase also produced acid soluble 
material (table 1). The radioactivity released 
reached a maximum value after 25 min incubation. 
The amount of acid soluble material produced 
varied between 0.1-O. 15% of the total mRNA 
radioactivity. Assuming uniform labelling and an 
average chain length of 1000 nucleotides for the poly- 
(a) containing microsomal mRNA from myeloma 
cells, this would suggest hat the enzyme has a 
cleaving efficiency of at least 50-75%. These cal- 
culations are based on the fact that all polyadenylated 
microsomal RNA are capped [lo] . 
Very often, mRNA isolated by oligo(dT)- 
cellulose chromatography contains traces of rRNA 
of high specific activity [ 121. Therefore it seems 
reasonable to assume that the actual efficiency of 
removal of the cap is higher. 
In order to confirm the identity of the cleavage 
product, the acid soluble material produced was 
subjected to DEAE-cellulose chromatography [7]. 
As expected 97% of the radioactivity eluted together 
with m7 GDP used as an optical marker (fig.2). By 
thin layer chromatography on PEI cellulose [ 131 
the radioactivity was shown to comigrate with 
standard m’ GDP kindly provided by Dr A. J. 
Shatkin (results not shown). 
Table 1 
Time course of the cleavage reaction 
Incubation period (min) Radioactivity recovered in the 
acid soluble fraction (%) 
5 0.04 
10 0.07 
15 0.11 
20 0.13 
25 0.14 
30 0.14 
Polyadenylated microsomal RNA labelled with [ %P]Pi was 
treated with polynucleotide kinase as described in the experi- 
mental section. The reaction was stopped at different time 
Intervals by adding 100 Mg rRNA and cold perchloric acid 
to 4% final concentration. 
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Fig.2. DEAE-cellulose chromatography of cold perchloric acid soluble material produced on polynucleotide kinase treatment 
of mRNA. [“P] P-labelled polyadenylated microsomal RNA (500 000 cpm) was treated with kinase as described in the 
! 
experimental sectron. Cold perchloric acid soluble material was neutralized with KOH and subjected to chromatography on 
a DEAE-cellulose column together with optimal markers as described by Nomoto et al. [7] The horizontal bars indicate the 
positions of optical markers. m’ GDP, GDP and GTP respectively (o -0) radioactivity (a -.)A 160 nm. 
4. Discussion 
Our results show that bacteriophage T4 induced 
polynucleotide kinase can cleave the 5’-5’ triphos- 
phate linkage of the cap structure producing m’ 
GDP. 
Recently two other enzymes able to cleave the 
5’-terminal blocking nucleotide have been reported 
[ 14,151. The enzyme activity present in HeLa cells 
[ 141 was specific for the cap structure. The tobacco 
phosphodiesterase [ 151 is less specific and was shown 
to cleave the pyrophosphate bond of NAD+ as well 
as the cap structure: The cleavage product produced 
from mRNA by both these enzymes was m’ GMP. 
Polynucleotide kinase in contrast, cleaves off m’ 
GDP from mRNA. Like mRNAs of prokaryotes and 
poliovirus, decapped mRNAs produced by poly- 
nucleotide kinase have a single phosphate group 
at the 5’-terminus. The enzyme can be purified to 
homogeneity free of nucleases [8] . Therefore this 
enzyme can be a useful tool for comparing the 
biological activity of capped and decapped mRNA. 
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